Applied Biosystems’ shares rose 11.3 percent for the trading week ended Tuesday to lead all stocks in the BCW Index. The firm’s stock rose following the release of its third-quarter results, which showed a 15-percent gain in revenue (see BioCommerce Week 10/25/2006). PerkinElmer’s stock gained 7.6 percent for the week, and Bruker Biosciences rose 6.1 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.